Outlook Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q4 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Outlook Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q4 2019 to Q4 2022.
  • Outlook Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2022 was $11.9K, a 2.94% increase year-over-year.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $27.7K, a 40.7% decline from 2022.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $46.7K, a 70.6% decline from 2021.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $159K, a 15.4% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $11.9K +$339 +2.94% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q4 2021 $11.5K -$37.2K -76.4% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q4 2020 $48.8K +$1.88K +4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q4 2019 $46.9K Oct 1, 2019 Dec 31, 2019 10-Q 2020-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.